鼻咽癌放疗后眼部并发症风险研究
本研究采用1:1倾向评分匹配,分析1997至2010年台湾全民健康保险研究数据库中鼻咽癌放疗患者(n=736)与非鼻咽癌头颈癌放疗患者(n=736),发现鼻咽癌组发生眼部并发症的调整风险比显著升高(调整HR=2.786,95%CI=1.805-4.112,P<0.001),最常见为视神经病变和视网膜病变。
要点
- 鼻咽癌放疗患者眼部并发症风险是非鼻咽癌头颈癌放疗患者的2.786倍。
- 随访12个月内及24个月后鼻咽癌组眼部并发症风险均显著增高(P<0.05)。
- 最常见眼部并发症为视神经病变和视网膜病变。
核心结论
- 鼻咽癌患者放疗后发生眼部并发症的风险高于非鼻咽癌头颈癌放疗患者。
- 建议进一步研究或由眼科医师进行常规评估。
研究设计与样本
- 采用1:1倾向评分匹配,鼻咽癌队列n=736,对照队列n=736(非鼻咽癌头颈癌放疗患者)。
- 数据来源于1997至2010年台湾全民健康保险研究数据库,随访至发生眼部并发症或2010年12月31日。
主要发现
- 鼻咽癌组发生眼部并发症的调整风险比为2.786(95%CI=1.805-4.112,P<0.001)。
- 随访12个月内及24个月后,鼻咽癌组眼部并发症风险均显著高于对照组(P<0.05)。
- 最常见眼部并发症为视神经病变和视网膜病变。
关键数值与推荐
- 眼部并发症依据ICD-9-CM编码360-379定义。
- 调整HR=2.786,95%CI=1.805-4.112,P<0.001。
临床怎么用
- 对鼻咽癌放疗患者应关注眼部并发症风险,可考虑眼科常规评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the risk of ocular complications following radiotherapy in patients with nasopharyngeal carcinoma (NPC). METHODS: We adopted 1:1 propensity score matching and identified an NPC cohort (n = 736) and a comparison cohort (n = 736) that comprised non-NPC head and neck cancer patients who received radiotherapy in the National Health Insurance Research Database from 1997 to 2010. The follow-up period was terminated upon developing ocular complications (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM]360-379) or on December 31, 2010. RESULTS: After adjusting for the confounding factors of the study, the NPC cohort had a higher adjusted hazard ratio (HR) for developing ocular complications than the comparison cohort (adjusted HR = 2.786, 95% confidence interval [CI] = 1.805-4.112, P < 0.001). The NPC cohort was associated with a significantly higher risk of developing ocular complications compared with the comparison cohort within 12 and after 24 months of follow-up (P < 0.05). The most common associated ocular complications were optic nerve disorder and retinopathy. CONCLUSIONS: Patients with NPC might be at higher risk of developing ocular complications after radiotherapy than non-NPC head and neck cancer patients in Taiwan. Either further investigation or routine assessments by ophthalmological physician is recommended. LEVEL OF EVIDENCE: NA Laryngoscope, 130:1270-1277, 2020.
引用
- Lin KT, Lee SY, Liu SC, et al. Risk of ocular complications following radiation therapy in patients with nasopharyngeal carcinoma. Laryngoscope. 2019. PMID: 31441954. doi:10.1002/lary.28254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。